Financial insights of AMLX

MyFinsight

For the quarter ending 2025-09-30.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Product revenue, net	0	0	-	-
Cost of sales	0	0	-	1,488,250
Cost of sales - inventory impairment and loss on firm purchase commitments	0	0	-	39,290,333.333
Acquired in-process research and development	0	-	-	0
Product revenue, net	-	-	-	28,985,000
Research and development	19,855,000	27,217,000	22,119,000	27,615,666.667
Selling, general and administrative	16,172,000	15,640,000	15,684,000	32,167,666.667
Restructuring expenses	0	0	-	5,712,750
Total operating expenses	36,027,000	42,857,000	37,803,000	108,675,000
Loss from operations	-36,027,000	-42,857,000	-37,803,000	-79,690,000
Interest income	1,821,000	1,960,000	2,231,000	3,570,333.333
Other expense, net	-180,000	-546,000	-335,000	-357,666.667
Total other income, net	1,641,000	1,414,000	1,896,000	3,212,666.667
Loss before income taxes	-34,386,000	-41,443,000	-35,907,000	-76,477,333.333
Provision for income taxes	0	0	-	-98,250
Net loss	-34,386,000	-41,443,000	-35,907,000	-76,346,333.333

Earnings per share, basic, total	-0.37	-0.46	-0.42	-1.12
Earnings per share, diluted, total	-0.37	-0.46	-0.42	-1.12
Weighted average number of shares outstanding, basic, total	93,332,930	89,138,568	85,697,108	16,904
Weighted average number of shares outstanding, diluted	93,332,930	89,138,568	85,697,108	16,904